Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Choroidal Neovascularization (CNV)”

343 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 343 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05407636
What this trial is testing

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+3 more
AbbVie 735
Large-scale testing (Phase 3)Study completedNCT00121407
What this trial is testing

Visudyne® in Occult (VIO)

Who this might be right for
Macular Degeneration
QLT Inc. 364
Not applicableStudy completedNCT03793400
What this trial is testing

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

Who this might be right for
Choroidal NeovascularizationPunctate Inner Choroidopathy
Changhua Christian Hospital 22
Post-approval studies (Phase 4)Looking for participantsNCT06709339
What this trial is testing

Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)

Who this might be right for
Polypoidal Choroidal Vasculopathy
Association for Innovation and Biomedical Research on Light and Image 120
Testing effectiveness (Phase 2)Study completedNCT01023295
What this trial is testing

Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Polypoidal Choroidal Vasculopathy
Mateon Therapeutics 20
Testing effectiveness (Phase 2)Study completedNCT00288561
What this trial is testing

Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration (ARMD)
Novartis
Not applicableUnknownNCT00383812
What this trial is testing

Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Asan Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00376701
What this trial is testing

Combination Therapy for Age-Related Macular Degeneration.

Who this might be right for
Age Related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 103
Not applicableStudy completedNCT04455399
What this trial is testing

Time Efficiency Comparison of Two IntraVitreal Injection Techniques

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion With Macular Edema+2 more
Peregrine Eye and Laser Institute 200
Not applicableStudy completedNCT01025063
What this trial is testing

Use of Spectral OCT in Combination Therapy

Who this might be right for
Choroidal Neovascularization
Barnes Retina Institute 15
Not applicableStudy completedNCT02287298
What this trial is testing

Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

Who this might be right for
Exudative Macular Degeneration
The Retina Center of St. Louis County, PC 400
Not applicableStudy completedNCT00345228
What this trial is testing

Myopic Macular Haemorrhages

Who this might be right for
Myopic Macular Haemorrhages
Singapore National Eye Centre 30
Large-scale testing (Phase 3)UnknownNCT00454389
What this trial is testing

Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
NeoVista 494
Large-scale testing (Phase 3)Study completedNCT06176352
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Choroidal Neovascularization Secondary to Pathologic Myopia
Hoffmann-La Roche 280
Testing effectiveness (Phase 2)Ended earlyNCT01122511
What this trial is testing

Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration

Who this might be right for
Subfoveal Choroidal NeovascularizationAge-Related Maculopathy
Allergan 4
Post-approval studies (Phase 4)Not Yet RecruitingNCT07187804
What this trial is testing

Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization

Who this might be right for
Age-related Macular Degeneration (ARMD)Choroidal NeovascularizationAnti-vascular Endothelial Growth Factor
Kim's Eye Hospital 30
Not applicableStudy completedNCT03459144
What this trial is testing

Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen

Who this might be right for
Polypoidal Choroidal Vasculopathy
Sun Yat-sen University 60
Not applicableStudy completedNCT04075188
What this trial is testing

Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid

Who this might be right for
Choroidal NeovascularizationChoroid Disease
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo 17
Testing effectiveness (Phase 2)WithdrawnNCT01015495
What this trial is testing

Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks

Who this might be right for
Angioid Streaks
University of Illinois at Chicago
Early research (Phase 1)UnknownNCT01217762
What this trial is testing

Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular DegenerationWet Age-Related Macular DegenerationMacular Degeneration+2 more
Oraya Therapeutics, Inc. 62
Next Page